Uncommon Therapeutics

A Disease Focused Biotech, Building Multiple Billion Dollar Drugs

HealthcareTherapeuticsGene TherapyCRISPRBiotechnology https://uncommontherapeutics.com ↗

Company facts

Early-stage
Founded
2025
Employees
2
Headquarters
United States

About

Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.